30.06.2025

Alithea Bio at #BayOConnect2025: Let’s Shape the Future of Immunotherapy

bayoconnect 2025 AlitheaBio
Contents hide
1 We’re excited to announce that Alithea Bio will be attending #BayOConnect2025 in Munich on 1–2 July 2025.
2 📍 Schedule a meeting with us to discuss

We’re excited to announce that Alithea Bio will be attending #BayOConnect2025 in Munich on 1–2 July 2025.

We’re excited to announce that Alithea Bio will be attending BayOConnect in Munich on 1–2 July 2025.

Our Chief Scientific Officer, Dr. Tim Fugmann, will be taking the stage on 2 July 2025, between 11:30 AM and 12:30 PM, to share insights into our cutting-edge work in immunotherapy.

📍 Schedule a meeting with us to discuss

  • Navigating peptide presentation with HLA-Compass

  • Discovering and validating target (neo)epitopes

  • Predicting off-target toxicity

  • Exploring our HLA-typed biorepository

If you’re attending the conference, we’d love to connect and explore how Alithea Bio can support your goals in immunotherapy, cancer research, and HLA-peptidomics.

Let’s shape the future of precision medicine together.

Read more

Alitheabio Linkedin

4,000 Strong: Celebrating Our Growing Community in Precision Immunotherapy

Read
HLA-Profiling-Mapping-the-Immune-Blueprint-for-Precision-Immunotherapy Alithea bio

Beyond Cancer: How Immunopeptidomics is Unlocking the Next Frontier in HIV Cure Research

Read
AI FOR GOOD ALITHEA BIO

Bridging the Gap Between AI and Immunity: Alithea Bio Named UN AI for Good Finalist

Read